Literature DB >> 26259122

Concordance with DASH diet and blood pressure change: results from the Framingham Offspring Study (1991-2008).

Jieying Jiang1, Mengling Liu, Lisa M Troy, Sripal Bangalore, Richard B Hayes, Niyati Parekh.   

Abstract

BACKGROUND: Concordance with the Dietary Approaches to Stop Hypertension (DASH) diet has been shown to reduce blood pressure (BP) in short-term intervention studies, but long-term effects are unclear. We evaluated the association of DASH diet concordance with BP trajectories and incidence of hypertension, in 2187 men and women (mean age 52.5 years at baseline) participating in the Framingham Offspring cohort.
METHOD: Diet and BP were assessed from 1991 to 2008, with a median follow-up time of 13.4 years. DASH scores (ranging from 0 for worst to 10 for best concordance with DASH diet) were calculated by summing 10 food components that comprise the DASH diet pattern, including fruits and vegetables, low-fat dairy products, lean meat, and plant-based protein. Mixed-effect and Cox regression models were applied, to assess the association of DASH diet concordance with BP longitudinal change and with incidence of hypertension, respectively. All analyses were adjusted for age, sex, smoking status, history of diabetes, BMI, and physical activity. RESULT: Overall, SBP increased by 0.34 mmHg and DBP by 0.10 mmHg annually, in the Framingham Offspring cohort. Every unit increase in the DASH score resulted in a modest increase in SBP of 0.054 mmHg/year (P = 0.028). No associations were observed between DASH diet concordance and DBP or incidence of hypertension.
CONCLUSION: Long-term concordance with the DASH diet was not associated with a decreasing BP trajectory over time, or with decreased incidence of hypertension, in this population of middle-aged adults.

Entities:  

Mesh:

Year:  2015        PMID: 26259122     DOI: 10.1097/HJH.0000000000000710

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  7 in total

Review 1.  Dietary Modifications and Lipid Accumulation Product Are Associated with Systolic and Diastolic Blood Pressures in the Women's Health Trial: Feasibility Study in Minority Populations.

Authors:  Alok Bhargava
Journal:  Curr Hypertens Rep       Date:  2018-05-19       Impact factor: 5.369

Review 2.  Lifestyle Modification in Secondary Prevention: Beyond Pharmacotherapy.

Authors:  Jenna Brinks; Amy Fowler; Barry A Franklin; Jassu Dulai
Journal:  Am J Lifestyle Med       Date:  2016-07-08

3.  Diagnostic status of hypertension on the adherence to the Dietary Approaches to Stop Hypertension (DASH) diet.

Authors:  Hyun Kim; Flavia C D Andrade
Journal:  Prev Med Rep       Date:  2016-09-28

4.  Blood pressure and expression of microRNAs in whole blood.

Authors:  Zhou Zhang; Brian Thomas Joyce; Jacob K Kresovich; Yinan Zheng; Jia Zhong; Ruchi Patel; Wei Zhang; Lei Liu; Chang Dou; John P McCracken; Anaité Díaz; Valeria Motta; Marco Sanchez-Guerra; Shurui Bian; Pier Alberto Bertazzi; Joel Schwartz; Andrea A Baccarelli; Sheng Wang; Lifang Hou
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

5.  Traditional risk factors for essential hypertension: analysis of their specific combinations in the EPIC-Potsdam cohort.

Authors:  Violetta Andriolo; Stefan Dietrich; Sven Knüppel; Wolfgang Bernigau; Heiner Boeing
Journal:  Sci Rep       Date:  2019-02-06       Impact factor: 4.379

6.  Longitudinal Associations between Monetary Value of the Diet, DASH Diet Score and the Allostatic Load among Middle-Aged Urban Adults.

Authors:  May A Beydoun; Amelie Nkodo; Marie T Fanelli-Kuczmarski; Ana I Maldonado; Hind A Beydoun; Barry M Popkin; Michele K Evans; Alan B Zonderman
Journal:  Nutrients       Date:  2019-10-03       Impact factor: 5.717

7.  Dietary Quality Associated with Self-Reported Diabetes, Osteoarthritis, and Rheumatoid Arthritis among Younger and Older US Adults: A Cross-Sectional Study Using NHANES 2011-2016.

Authors:  Masako Matsunaga; Eunjung Lim; James Davis; John J Chen
Journal:  Nutrients       Date:  2021-02-07       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.